Discharge of the asthmatic patient

B. A. Markoff, John MacMillan Jr, V. Kumra

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Asthma continues to be a challenging disease to treat in both the inpatient and outpatient settings. The growing database on therapeutic interventions at the time of transition from the acute to chronic phase of this disease is encouraging. Glucocorticoids and inhaled β-agonists clearly reduce readmission and relapse. other medications and educational interventions also appear effective. Still, no true discharge guidelines have been established. Multiple statements by consensus panels have recommended using FEV1 or PEFR as indicators of readiness for discharge, but this has not been prospectively validated from either the emergency department or patient setting. In contrast, some studies argue that pulmonary function do not accurately predict relapse and readmission, so the usefulness of these discharge recommendations is debatable. Large studies, especially in the adult asthmatic population, are needed to validate these recommendation.

Original languageEnglish (US)
Pages (from-to)341-355
Number of pages15
JournalClinical Reviews in Allergy and Immunology
Volume20
Issue number3
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Discharge of the asthmatic patient'. Together they form a unique fingerprint.

  • Cite this